Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy.
about
The effectiveness and safety of same-day versus next-day administration of long-acting granulocyte colony-stimulating factors for the prophylaxis of chemotherapy-induced neutropenia: a systematic reviewRisk of chemotherapy-induced febrile neutropenia by day of pegfilgrastim prophylaxis in US clinical practice from 2010 to 2015."Same-Day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationale.
P2860
Evaluation of the Hematologic Safety of Same Day Versus Standard Administration (24- to 72-Hour Delay) of Pegfilgrastim in Gynecology Oncology Patients Undergoing Cytotoxic Chemotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Evaluation of the Hematologic ...... rgoing Cytotoxic Chemotherapy.
@en
type
label
Evaluation of the Hematologic ...... rgoing Cytotoxic Chemotherapy.
@en
prefLabel
Evaluation of the Hematologic ...... rgoing Cytotoxic Chemotherapy.
@en
P2093
P50
P1476
Evaluation of the Hematologic ...... rgoing Cytotoxic Chemotherapy.
@en
P2093
Aleia K Crim
David M O'Malley
Jeffrey M Fowler
Larry J Copeland
Ritu Salani
Samuel N Jacobson
Sarah M Crafton
P304
P356
10.1097/IGC.0000000000000487
P577
2015-06-09T00:00:00Z